Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): Fungal Infections

This chapter explores evidence-based pharmacist care in fungal infections through clinical, economic, and humanistic lenses. Clinically, pharmacists optimize antifungal selection and dosing via stewardship and therapeutic drug monitoring, promptly identify and manage drug–drug interactions and adverse effects, and facilitate early diagnosis and multidisciplinary coordination to improve cure rates and reduce morbidity. Economically, interventions such as generic substitution, IV-to-oral transitions, and medication-use evaluations shorten hospital stays, prevent readmissions, and yield significant per-patient cost savings. From a humanistic perspective, personalized patient education, adherence support, and empathetic counseling enhance health literacy, self-efficacy, and quality of life, while reducing stigma and anxiety associated with chronic or severe infections. Drawing on randomized trials, cohort studies, and pharmacoeconomic analyses, the chapter identifies best practices, quantifies pharmacist-driven outcomes, and highlights facilitators (interprofessional collaboration, 72 digital tools, ongoing training) and barriers (regulatory limits, time constraints, reimbursement challenges). Standardized metrics and implementation frameworks are proposed to guide the sustainable integration of pharmacist-led care in fungal infection management.